ArticleTropical animal health and production2026
Low BVDV antigen prevalence in dairy cattle in the Emirate of Abu Dhabi, UAE: a cross-sectional study with regional comparison.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bovine viral diarrhoea virus (BVDV) is an economically important cattle pathogen, yet epidemiological data from commercial dairy herds in the United Arab Emirates (UAE) are lacking. This cross-sectional study estimated animal- and herd-level BVDV antigen prevalence in commercial dairy herds in the Emirate of Abu Dhabi, UAE, and compared the findings with published regional and global prevalence estimates. A total of 681 adult female Holstein-Friesian cattle from nine dairy farms were sampled using a stratified systematic approach and tested for BVDV antigen by antigen-capture ELISA. Published antigen- and RT-PCR-based prevalence data from neighbouring Middle Eastern countries and global systematic reviews were subsequently examined for comparison. The apparent animal- and herd-level antigen prevalences were 1.02% (7/681; 95% CI: 0.27-1.79%) and 33.3% (3/9 farms), respectively. Within-herd prevalence ranged from 0% to 9.1%, with no antigen-positive-animals detected in six herds. Comparative analysis (Chi-square test, p < 0.05) showed that the animal-level antigen prevalence in the UAE was significantly lower than those from Iraq (5.46-7.10%) and Saudi Arabia (12.00%) (p < 0.001), while remaining within the range reported for East Asia but below pooled estimates for West Asia. The relatively low prevalence is likely associated with routine vaccination implemented across the participating farms. These findings provide the first BVDV antigen prevalence estimates in commercial dairy cattle in the UAE and establish an important epidemiological baseline for national surveillance and BVD control. Future genotyping of circulating BVDV strains are warranted to support evidence-based vaccine selection and optimize control programs in the UAE.
Indexed as
Identifiers
42521906What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.